Skip to main content

Johns Hopkins UniversityEst. 1876

America’s First Research University
Archived articles

Immunotherapy

Marina Baretti and Mark Yarchoan
Research in action
As liver cancer rates surge, new treatments offer hope
Published Sept 16, 2025
Medical researchers at Johns Hopkins aim to accelerate therapies that improve and save lives as liver cancer becomes one of the most common cancers in the U.S.
Maximilian Konig
Research matters
Breakthrough autoimmune treatments slowed
Published June 24, 2025
Federal budget cuts have created "a climate of anxiety" among medical researchers, says Maximilian F. Konig, a rheumatologist at Johns Hopkins. But those who live with autoimmune diseases could suffer the greatest consequences.
Andrew Ewald
Research matters
Biological targets could halt breast cancer metastasis
Published April 9, 2025
Thanks to the NIH, researchers like Andrew Ewald have advanced our understanding of what allows a cancer cell from one part of the body to successfully grow in another part
Vanessa
Research in action
A miracle in her own backyard
Published March 10, 2025 Video
NIH clinical trials are a lifeline for cancer patients like Baltimore native Vanessa, who received a groundbreaking immunotherapy treatment at the Kimmel Cancer Center
Benjamin Biggs
Student Scholar
Biomedical engineering doctoral student named Quad Fellow
Published Aug 16, 2024
Benjamin Biggs among recipients of highly competitive award for exceptional master's and doctoral students to study STEM in the U.S.
An illustration of a person
Immunotherapy
Toxic trade-offs
Published March 17, 2023
While advances in immunotherapy have dramatically improved cancer survival, unleashing the immune system can lead to a host of adverse reactions. How can patients pay less of a price?
Artist's rendering of tumor cells
Cancer research
Machine learning can help predict patient response to cancer immunotherapy
Published Nov 17, 2022
Algorithm gives insights into the biology behind an effective immune response
Melanoma cells
Cancer research
FDA approves new immunotherapy treatment regimen for melanoma patients
Published March 25, 2022
The treatment was developed and studied by researchers at Johns Hopkins and targets aggressive forms of skin cancer
Elizabeth Jaffee and First Lady Jill Biden, both wearing masks, pose for a photo together at the the White House
Q+A
Cancer Moonshot renewal could bring ambitious goals within reach
Published Feb 8, 2022
Johns Hopkins cancer researcher Elizabeth Jaffee, who co-led the Cancer Moonshot Blue Ribbon Panel in 2016, discusses how far cancer research has come in the past five years and where it's headed in the next few decades
T-cells attacking tumor cells, a process facilitated by immunotherapy
Cancer research
Pioneering method examines how immunotherapy changes tumors
Published Oct 13, 2021
The non-invasive technique using an optical probe provides early signs of how a tumor is responding to treatment